Neurotoxicity of combination chemotherapy with procarbazine, CCNU and vincristine (PCV) for recurrent glioma

Journal of Neuro-Oncology

Volumn 38, Issue 1, 1998, Pages 69-75

  Postma, T J ^a   Van Groeningen, C J ^a   Witjes, R J G M ^a   Weerts, J G E ^a   Kralendonk, J H ^a   Heimans, J J ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Central neurotoxicity; Glioma; PCV chemotherapy

Indexed keywords

ANTICONVULSIVE AGENT; ANTINEOPLASTIC AGENT; LOMUSTINE; PROCARBAZINE; VINCRISTINE;

ADULT; ARTICLE; BLOOD TOXICITY; BONE MARROW SUPPRESSION; BRAIN ATROPHY; CANCER RECURRENCE; CASE REPORT; ELECTROENCEPHALOGRAM; FEMALE; GLIOMA; HUMAN; LIVER TOXICITY; MALE; NEUROTOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING;

ADULT; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; FEMALE; GLIOBLASTOMA; GLIOMA; HUMANS; LOMUSTINE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OLIGODENDROGLIOMA; PROCARBAZINE; VINCRISTINE;

EID: 0031885014     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005909318270     Document Type: Article

References (29)

1. Fine HA, Dear KBG, Loeffler JS, Black PM, Canellos GP: Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer 71: 2585-2597, 1993
2. Yung WKA, Levin VA: Chemotherapy: current and future role and expectations. In: Malignant cerebral gliomas: Neurosurgical topics. American Association of Neurologic Surgeons 207-216, 1990
3. Levin VA, Wara WM, Davis RL, Vestnys P, Resser KJ, Yatsko K, Nutik S, Gutin PH, Wilson CB : Phase III comparison of BCNU and the combination of procarbazine, CCNU, and vincristine administered after radiotherapy with hydroxyurea for malignant gliomas. J Neurosurg 63: 218-223, 1985
4. Levin VA, Silver P, Hannigan J, Wara WM, Gutin PH, Davis RL, Wilson CB: Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarbazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report. Int J Radiat Oncol Biol Phys 18: 321-324, 1990
5. Cairncross JG, Macdonald DR: Successful chemotherapy for recurrent malignant oligodendroglioma. Ann Neurol 23: 360-364, 1988
6. Cairncross JG, Macdonald DR: Chemotherapy for oligodendroglioma. Progress report. Arch Neurol 48: 225-227, 1991
7. Macdonald DR, Gaspar LE, Cairncross JG: Successful chemotherapy for newly diagnosed aggressive oligodendroglioma. Ann Neurol 27: 573-574, 1990
8. Cairncross JG, Macdonald D, Ludwin S, Lee D, Cascino T, Bucker J, Fulton D, Dropcho E, Stewart D, Schold C Jr, Wainman N, Eisenhauer E: Chemotherapy for anaplastic oligodendroglioma. J Clin Oncol 12: 2013-2021, 1994
9. Glass J, Hochberg FH, Gruber ML, Louis DN, Smith D, Rattner B : The treatment of oligodendrogliomas and mixed oligodendroglioma-astrocytomas with PCV chemotherapy. J Neurosurg 76: 741-745, 1992
10. Mason WP, Krol GS, DeAngelis LM: Low-grade oligodendroglioma responds to chemotherapy. Neurology 46: 203-207, 1996
11. Levin VA, Edwards MS, Wright DC, Seager ML, Fischer Schimberg T, Townsend JJ, Wilson CB: Modified procarbazine, CCNU, and vincristine (PCV 3) combination chemotherapy in the treatment of malignant brain tumors. Cancer Treat Rep 64: 237-241, 1980
12. Salgado D, Costa I, Pimentel T, Oliveira P, Pimentel J, Bravo Marques JM: PCV for anaplastic oligodendroglioma. 'Abstract'. J Neurooncol 30: 150, 1996
13. Macdonald DR, Cascino TL, Schold SC Jr, Cairncross JG: Response criteria for Phase II studies of supratentorial malignant glioma. J Clin Oncol 8: 1277-1280, 1990
14. Constine LS, Konski A, Ekholm S, McDonald S, Rubin P: Adverse effects of brain irradiation correlated with MR and CT imaging. Int J Radiat Oncol Biol Phys 15: 319-330, 1988
15. Sheline GE, Wara WM, Smith V: Therapeutic irradiation and brain injury. Int J Radiat Oncol Biol Phys 6: 1215-1228, 1980
16. Al-Mefty O, Kersh JE, Routh A, Smith RR: The long-term side effects of radiation therapy for benign brain tumors in adults. J Neurosurg 73: 502-512, 1990
17. Valk PE, Dillon WP: Radiation injury of the brain. AJNR 12: 45-62, 1991
18. Lee JS, Umsawasdi T, Lee Y-Y, Barkley HT, Murphy WK, Welch S, Valdivieso M: Neurotoxicity in long-term survivors of small cell lung cancer. Int J Radiat Oncol Biol Phys 12: 313-321, 1986
19. Mahler P, Griffin B, Geyer JR, Bleyer WA: Chemoradiotherapy interactions and the blood-brain barrier. In: Neuwelt EA (ed) Implications of the Blood-Brain Barrier and its Manipulation, Volume 2, Clinical aspects. Plenum Medical Book Company, New York and London 373-387, 1989
20. Ney GC, Lantos G, Barr WB, Schaul N: Cerebellar atrophy in patients with long-term phenytoin exposure and epilepsy. Arch Neurol 51: 767-771, 1994
21. Botez MI, Attig E, Vézina JL: Cerebellar atrophy in epileptic patients. Can J Neurol Sci 15: 299-303, 1988
22. Papazian O, Cañizales E, Alfonso I, Archila R, Duchowny M, Aicardi J: Reversible dementia and apparent brain atrophy during valproate therapy. Ann Neurol 38: 687-691, 1995
23. McLachlan RS: Pseudoatrophy of the brain with valproic acid monotherapy. Can J Neurol Sci 14: 294-296, 1987
24. Salinsky MC, Oken BS, Binder LM: Assessment of drowsiness in epilepsy patients receiving chronic antiepileptic drug therapy. Epilepsia 37: 181-187, 1996
25. Meador KJ, Loring DW, Abney AL, Allen ME, Moore EE, Zamrini EY, King DW: Effects of carbamazepine and phenytoin on EEG and memory in healthy adults. Epilepsia 34: 153-157, 1993
26. Salinsky MC, Oken BS, Morehead L: Intraindividual analysis of antiepileptic drug effects on EEG background rhythms. Electroencephal Clin Neurophysiol 90: 186-193, 1994
27. Sandberg-Wollheim M, Malmström P, Strömblad L-G, Anderson H, Borgström S, Brun A, Cronqvist S, Hougaard K, Salford LG: A randomized study of chemotherpay with procarbazine, vincristine and lomustine with and without radiation therapy for astrocytoma grades 3 and/or 4. Cancer 68: 22-29, 1991
28. Weiss HD, Walker MD, Wiernik PH: Neurotoxicity of commonly used antineoplastic agents (second of two parts). N Engl J Med 291: 127-133, 1974
29. Corn BW, Yousem DM, Scott CB, Rotman M, Asbell SO, Nelson DF, Martin L, Curran WJ Jr: White matter changes are correlated significantly with radiation dose. Cancer 74: 2828-2835, 1994